Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: results from an open-label trial
Pharmacology, Toxicology and Pharmaceutical Science
11
9%
Biochemistry, Genetics and Molecular Biology
7
6%
Agricultural and Biological Sciences
5
4%
Immunology and Microbiology
5
4%
Other
9
8%
Unknown
32
27%
Attention Score in Context
Attention Score in Context
This research output has an Altmetric Attention Score of 23. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 June 2024.
All research outputs
#1,896,930
of 29,868,835 outputs
Outputs from BMC Infectious Diseases
#502
of 9,801 outputs
Outputs of similar age
#16,362
of 247,187 outputs
Outputs of similar age from BMC Infectious Diseases
#8
of 154 outputs
Altmetric has tracked 29,868,835 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 9,801 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.2. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 247,187 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 154 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.
